
Keywords: MCV1; first dose of measles-containing vaccine; WHO; World Health Organization; PICOS; participants, interventions, comparisons, outcomes, study design; RVC; Regional Verification Commission; PRNT; plaque reduction neutralization test; GMT; geometric mean